126100-97-8 Usage
General Description
Dimiracetam is a novel nootropic compound designed to enhance cognition and memory function. It belongs to the racetam family of compounds and is synthesized by modifying the chemical structure of piracetam. Dimiracetam is thought to exert its cognitive-enhancing effects by modulating the activity of various neurotransmitters in the brain, such as acetylcholine and glutamate. This modulation is believed to result in improved memory formation and learning ability. Dimiracetam is also thought to have neuroprotective properties, which may be beneficial in preventing age-related cognitive decline and protecting the brain from certain types of damage. Overall, Dimiracetam shows promise as a potential enhancer of cognitive function, although more research is needed to fully understand its mechanisms of action and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 126100-97-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,1,0 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 126100-97:
(8*1)+(7*2)+(6*6)+(5*1)+(4*0)+(3*0)+(2*9)+(1*7)=88
88 % 10 = 8
So 126100-97-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O2/c9-5-3-8-4(7-5)1-2-6(8)10/h4H,1-3H2,(H,7,9)
126100-97-8Relevant articles and documents
PROCESS FOR THE PREPARATION OF DIMIRACETAM
-
Page/Page column 7-8, (2012/02/13)
The invention relates to a method of manufacture of dimiracetam (2,5-dioxohexahydro-1 H-pyrrolo[1,2-a]imidazole), characterized in that a 4-oxo-butanoic acid ester is condensed with glycinamide in a one-pot reaction with a controlled pH. The reaction may be performed in aqueous solution or in an anhydrous lower alcohol solution.
Psychotropic perhydroazacycloalka [1,2-A] imidazole derivatives
-
, (2008/06/13)
Imidazole derivatives are described which are useful in restoring learning and treating memory difficulties. A compound of the invention is 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole.
